MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

23 Apr 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. In this regard, the company has enclosed a press release on 23rd April 2021.

The above information is a part of company’s filings submitted to BSE.





Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..